Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
Oct 25, 2012 brown michael s Director Option Execute 2,000 23.84
Oct 25, 2012 schleifer leonard s Officer Disposition (Non Open Market) 75,938 n/a
Oct 25, 2012 van plew daniel p Officer Disposition (Non Open Market) 16,043 159.55
Oct 25, 2012 van plew daniel p Officer Option Execute 30,000 21.92
Oct 9, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,392 n/a
Sep 19, 2012 powchik peter Officer Automatic Sell 7,177 146.89 - 148.00
Sep 18, 2012 powchik peter Officer Automatic Sell 7,823 148.78
Sep 18, 2012 powchik peter Officer Option Execute 15,000 16.80
Sep 6, 2012 baker charles a Director Automatic Sell 13,714 150.00
Sep 6, 2012 baker charles a Director Option Execute 13,714 15.01
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Sep 4, 2012 roberts william Officer Acquisition (Non Open Market) 19,947 n/a
Sep 4, 2012 vagelos p roy Officer Disposition (Non Open Market) 19,947 n/a
Aug 31, 2012 goldberg murray a Officer Automatic Sell 5,296 144.59 - 147.21
Aug 29, 2012 stahl neil Officer Sell 16,884 144.92 - 146.41
Aug 28, 2012 stahl neil Officer Disposition (Non Open Market) 23,116 145.70
Aug 28, 2012 stahl neil Officer Option Execute 40,000 21.92
Aug 27, 2012 mccorkle douglas s Officer Disposition (Non Open Market) 256 145.23
Aug 24, 2012 mccorkle douglas s Officer Automatic Sell 6,727 142.71 - 146.07
Showing 341-360 of 834 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)